Alessandra Decina

Innovation Forum Follow Prof. Patrizia Paterlini Brechot, Founder & CSO of Rarecells Diagnostics, in the panel discussion “Prevention, early detection and future therapies in oncology” at Health Horizons Future Healthcare Forum in #Cambridge Innovation Forum Find out more here: https://www.horizons.health/

The Italian newspaper “La Nazione” dedicated a long article to Prof. Patrizia Paterlini-Bréchot’s nomination for the European Inventors Awards in the category “Research” and to its invention the ISET Technique.

Rarecells Diagnostics, a leading company in the field of Liquid Biopsy, announces today that the European Patent Office (EPO) has nominated Professor Patrizia Paterlini-Bréchot, as one of the three finalists of the European Inventor Award 2019 – category “Research”- for developing ISET®, a new diagnostic blood test for cancer (www.isetbyrarecells.com). The highly-sensitive ISET® test detects circulating tumour cells which play

http://www.TriConference.com Rarecells Diagnostics is a corporate support sponsor of CHI’s Molecular Medicine Tri-Conference taking place on March 10-15, 2019 in San Francisco.  Our guests can attend at a $200 discount* when registering online with keycode RAE200. *This applies to new registrations and can’t be combined with any other offer.  Not valid on short course only